SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — FibroGen Inc. (FGEN) on Monday reported net income of $18 million in its fourth quarter.
The San Francisco-based company said it had profit of 18 cents per share. Losses, adjusted to account for discontinued operations, came to 8 cents per share.
The biotech drug developer posted revenue of $3.1 million in the period.
For the year, the company reported a loss of $47.6 million, or 48 cents per share. Revenue was reported as $29.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FGEN at https://www.zacks.com/ap/FGEN
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
